Your browser doesn't support javascript.
loading
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.
Wakelee, Heather; Zvirbule, Zanete; De Braud, Filippo; Kingsley, C Daniel; Mekhail, Tarek; Lowe, Thomas; Schütte, Wolfgang; Lena, Hervé; Lawler, William; Braiteh, Fadi; Cosgriff, Thomas; Kaen, Diego; Boyer, Michelle; Hsu, Jessie; Phan, See; Novello, Silvia.
Affiliation
  • Wakelee H; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA. Electronic address: hwakelee@stanford.edu.
  • Zvirbule Z; Medical Oncology Department, Riga Eastern Clinical University Hospital, Latvian Oncology Center, Riga, Latvia.
  • De Braud F; Medical Oncology Department, National Cancer Institute of Milan, Milan, Italy.
  • Kingsley CD; Clearview Cancer Institute, Huntsville, AL.
  • Mekhail T; Department of Hematology/Oncology, Florida Hospital, Orlando, FL.
  • Lowe T; Department of Medical Oncology, Cancer Care Associates Medical Group, Inc, Redondo Beach, CA.
  • Schütte W; Department of Internal Medicine II, Martha-Maria Krankenhaus Halle-Dölau gGmbH, Halle, Germany.
  • Lena H; Pneumology Service, Hôpital Pontchaillou, Rennes, France.
  • Lawler W; St Jude Heritage Medical Group, Fullerton, CA.
  • Braiteh F; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Henderson, NV.
  • Cosgriff T; Division of Hematology/Oncology, Crescent City Research Consortium, Marrero, LA.
  • Kaen D; Centro Oncologico Riojano Integral (CORI), La Rioja, Argentina.
  • Boyer M; Department of Clinical Science, F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK.
  • Hsu J; Biostatistics Department, Product Development Oncology, Genentech Inc., San Francisco, CA.
  • Phan S; Biostatistics Department, Product Development Oncology, Genentech Inc., San Francisco, CA.
  • Novello S; Department of Oncology, AOU San Luigi-Orbassano, University of Turin, Turin, Italy.
Clin Lung Cancer ; 18(1): 50-59, 2017 01.
Article in En | MEDLINE | ID: mdl-27856142

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2017 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2017 Type: Article